Genetic characterization of sabin types 1 and 3 poliovaccine virus following serial passage in the human intestinal tract
The DOI matches its Crossref record; 26 of the 28 references it cites were found in a registry or an index.
Abstract
Poliovirus isolates types 1 and 3 were obtained from five and seven successive passages respectively, in infants who had been fed monovalent OPV in two separate clinical trials conducted in 1960. The purpose of these trials was to answer the question how much the vaccine virus would revert to its original neurovirulent phenotype following multiplication in the intestinal tract. Human passages were performed either by contact exposure or by feeding the excreted virus while the infants were maintained in isolation. Several virus isolates were obtained at each passage level. Infants participating in both studies showed no symptoms of disease. Antigenic studies (McBride, van Wezel) and protein analysis (PAGE) of the isolates, reported earlier from this laboratory, had shown that the isolates remained vaccine-like, although isolates from the later passages revealed some differences. Monkey neurovirulence test results showed that for both types 1 and 3 viruses the loss of attenuation of the vaccine strain upon passage was gradual, although the loss was faster for type 3. Examination of the oligonucleotide maps demonstrated that the oligonucleotide configuration of the isolates remained the same as for the vaccine strain but there was an increase of individual spot differences with increasing passage. The nucleotide sequence analysis of selected regions of the virus genomes revealed that there was no change from a G to A in nucleotide 480 of type 1 isolates; however, nucleotide 476…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There are cases of paralytic polio due to the loss of viral attenuation in the oral poliovirus vaccine (OPV), known as vaccine-derived poliovirus (VDPV).”
From The Fight against Poliovirus Is Not Over (2023) · cites this paper as [12]
In the citing paper
“A long-standing disadvantage of using OPVs is that attenuated vaccine strains can revert to a neuropathogenic phenotype during their replication in the intestinal tract [9,10,11,12,13,14].”
From The Fight against Poliovirus Is Not Over (2023) · cites this paper as [12]
In the citing paper
“These viruses with regained virulence incorporate a number of mutations that increase the structural stability of domV (Contreras et al., 1992, Davis et al., 1977, Dunn et al., 1990).”
From Engineering the Live-Attenuated Polio Vaccine to Prevent Reversion to Virulence (2020) · cites this paper as Contreras et al., 1992
Citations
Cites
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Molecular Cloning. A Laboratory Manual
Wood, E. (1983) · Biochemical Education · doi:10.1016/0307-4412(83)90068-7 · Cited by 29,533
PCR protocols — A guide to methods and applications
(1990) · Trends in Genetics · doi:10.1016/0168-9525(90)90186-a · Cited by 11,781
WHO Expert Committee on Biological Standardization.
Horowitz, B., Minor, P., Jj, M., Burnouf, T., McIntosh, R., Padilla, A., Thorpe, R., & van Aken, W. G. (1994) · PubMed · Cited by 534
Kawasaki, E. S. (1990) · PCR Protocols · doi:10.1016/b978-0-12-372180-8.50007-x · Cited by 474
Evans, D. M. A., Dunn, G., Minor, P. D., Schild, G. C., Cann, A. J., Stanway, G., Almond, J. W., Currey, K., & Maizel, J. V. (1985) · Nature · doi:10.1038/314548a0 · Cited by 440
Geographic distribution of wild poliovirus type 1 genotypes
Rico-Hesse, R., Pallansch, M. A., Nottay, B. K., & Kew, O. M. (1987) · Virology · doi:10.1016/0042-6822(87)90001-8 · Cited by 328
Complete nucleotide sequence of the attenuated poliovirus Sabin 1 strain genome.
Nomoto, A., Omata, T., Toyoda, H., Kuge, S., Horie, H., Kataoka, Y., Genba, Y., Nakano, Y., & Imura, N. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.19.5793 · Cited by 308
Skinner, M. A., Racaniello, V. R., Dunn, G., Cooper, J., Minor, P. D., & Almond, J. W. (1989) · Journal of Molecular Biology · doi:10.1016/0022-2836(89)90261-1 · Cited by 297
Genetic basis of attenuation of the Sabin type 3 oral poliovirus vaccine
Westrop, G. D., Wareham, K. A., Evans, D. M., Dunn, G., Minor, P. D., Magrath, D. I., Taffs, F., Marsden, S., Skinner, M. A., & Schild, G. C. (1989) · Journal of Virology · doi:10.1128/jvi.63.3.1338-1344.1989 · Cited by 233
Research works printed but not linked: 2
- MacLeod, 1966, The neurovirulence of the type 3 Sabin vaccine strain after passage in infants, Can J Public Health, 57, 37
- Geliebter, 1987, Dideoxynucleotide Sequencing of RNA and uncloned cDNA, Focus, 9, 5
Cited by
Engineering attenuated virus vaccines by controlling replication fidelity
Vignuzzi, M., Wendt, E., & Andino, R. (2008) · Nature Medicine · doi:10.1038/nm1726 · Cited by 282
Engineering the Live-Attenuated Polio Vaccine to Prevent Reversion to Virulence
Yeh, M. T., Bujaki, E., Dolan, P. T., Smith, M., Wahid, R., Konz, J., Weiner, A. J., Bandyopadhyay, A. S., Van Damme, P., De Coster, I., et al. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.04.003 · Cited by 221
Georgescu, M. M., Delpeyroux, F., Tardy-Panit, M., Balanant, J., Combiescu, M., Combiescu, A. A., Guillot, S., & Crainic, R. (1994) · Journal of Virology · doi:10.1128/jvi.68.12.8089-8101.1994 · Cited by 109
Tebbens, R. J. D., Pallansch, M. A., Kim, J., Burns, C. C., Kew, O. M., Oberste, M. S., Diop, O. M., Wassilak, S. G. F., Cochi, S. L., & Thompson, K. M. (2013) · Risk Analysis · doi:10.1111/risa.12022 · Cited by 105
Macadam, A. J., Ferguson, G., Stone, D. M., Meredith, J., Knowlson, S., Auda, G., Almond, J. W., & Minor, P. D. (2006) · Journal of Virology · doi:10.1128/jvi.00370-06 · Cited by 89
Metadata
- Authors
- Contreras, G., Dimock, K., Furesz, J., Gardell, C., Hazlett, D., Karpinski, K., McCorkle, G., & Wu, L.
- Affiliations
- University of Ottawa (CA)
- Health Canada (CA)
- Corresponding author
- Furesz, J.
- Venue
- Biologicals
- Publisher
- Elsevier BV
- Published
- 1992-03
- Volume
- 20
- Issue
- 1
- Pages
- 15-26
- ISSN
- 1045-1056 (ISSN-L)
- OpenAlex
- W2012921340
- Cited by
- 27
- References
- 28
- Citations by year
- 2026: 1 · 2023: 1 · 2020: 1 · 2015: 2 · 2014: 2 · 2013: 1
- FWCI
- 1.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Biologicals (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
- Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Evolution and Genetic Dynamics
- Keywords
- oral polio vaccine, poliovirus type 1, poliovirus type 3, vaccine attenuation, neurovirulence, nucleotide changes, genetic characterization, vaccine reversion, infants
- MeSH terms
- Base Sequence, DNA, Viral, Humans, Infant, Intestines, Molecular Sequence Data, Poliovirus Vaccine, Oral, Reference Standards, Species Specificity, Virulence, Virus Replication, Poliovirus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Genetic characterization of sabin types 1 and 3 poliovaccine virus following serial passage in the human intestinal tract. https://app.cochat.ai/papers/10.1016/s1045-1056(05)80003-x
- The paper
- Contreras, G., Dimock, K., Furesz, J., Gardell, C., Hazlett, D., Karpinski, K., McCorkle, G., & Wu, L. (1992). Genetic characterization of sabin types 1 and 3 poliovaccine virus following serial passage in the human intestinal tract. Biologicals. https://doi.org/10.1016/s1045-1056(05)80003-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.